Kaysen GA , Kotanko P, Zhu F ,Sarkar S, Heymsfield SB, Kuhlmann MK, Levin NW. Estimation of adipose pools in hemodialysis patients from anthropometric measures. J Renal Nutrition. 2008.
Hsu J, Johansen KL, Hsu CY, Kaysen GA, Chertow GM. Higher serum creatinine concentrations in black patients with chronic kidney disease: beyond nutritional status and body composition. Clin J Am Soc Nephrol, 2008. 3(4): 992-7.
Kaysen GA, Kotanko P, Zhu F, Sarkar SR, Heymsfield SB, Kuhlmann MK, Dwyer T, Usvyat L, Havel P, Levin NW. Relationship between adiposity and cardiovascular risk factors in prevalent hemodialysis patients. J Ren Nutr, 2009. 19(5): 357-64.
Kaysen GA. Potential restoration of HDL function with apolipoprotein A-I mimetic peptide in end-stage renal disease. Kidney Int, 2009. 76(4): 359-61.
Anderson S, Halter JB, Hazzard WR, Himmelfarb J, Horne FM, Kaysen GA, Kusek JW, Nayfield SG, Schmader K, Tian Y, Ashworth JR, Clayton CP, Parker RP, Tarver ED, Woolard NF, High KP,. Prediction, progression, and outcomes of chronic kidney disease in older adults. J Am Soc Nephrol, 2009. 20(6): 1199-209.
Kutner NG, Johansen KL, Kaysen GA, Pederson S, Chen SC, Agodoa LY, Eggers PW, Chertow GM. The comprehensive dialysis study (CDS): a USRDS special study. Clin J Am Soc Nephrol, 2009. 4(3): 645-50.
Kaysen GA. New insights into lipid metabolism in chronic kidney disease: what are the practical implications? Blood Purif, 2009. 27(1): 86-91.
Kaysen GA. Lipid and lipoprotein metabolism in chronic kidney disease. J Ren Nutr, 2009. 19(1): 73-7.